Dow Up 1.13% Nasdaq Up 1.41%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
4.83 Down 0.03(0.62%) 4:00PM EDT
- Nasdaq Real Time Price
Prev Close:4.86
Open:5.00
Bid:4.83 x 3500
Ask:4.84 x 2100
1y Target Est:8.33
Beta:2.03
Next Earnings Date: 7-Nov-14PGNX Earnings announcement
Day's Range:4.78 - 5.00
52wk Range:3.10 - 7.45
Volume:425,286
Avg Vol (3m):889,406
Market Cap:335.95M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

┬╗ More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 0.62%335.95M
DNDNDown 4.90%152.24M
NKTRDown 1.71%1.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback